Nantahala Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Hold |
205,760
| – | – | 0.01% | 128 |
|
|
2025
Q1 | $420K | Hold |
205,760
| – | – | 0.02% | 118 |
|
|
2024
Q4 | $677K | Hold |
205,760
| – | – | 0.03% | 108 |
|
|
2024
Q3 | $566K | Hold |
205,760
| – | – | 0.03% | 106 |
|
|
2024
Q2 | $837K | Hold |
205,760
| – | – | 0.05% | 97 |
|
|
2024
Q1 | $1.38M | Buy |
+205,760
| New | +$1.38M | 0.08% | 84 |
|